Health and Wellness

Why America’s $4.5 Trillion Healthcare System Can’t Afford To Stay The Same

The recent surge in criticism towards the health insurance industry has shed light on the deep frustration and anger felt by millions of Americans towards the current state of healthcare

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

China criticizes U.S. for withdrawing from World Health Organization

China has strongly criticized the United States for its decision to withdraw from the World Health Organization (WHO), emphasizing the

Food dye, TrumpRx, gender affirming care: Morning Rounds

Stay informed about health and medicine news every weekday by subscribing to STAT’s free newsletter Morning Rounds. Sign up here.

Roivant immune drug significantly outperformed placebo in treating rare skin disease

Roivant and its spinout Priovant made a groundbreaking announcement on Friday regarding their immune-modifying drug brepocitinib. The drug has shown

MAHA, others adopt anti-Big Tobacco strategies to fight Big Food

The company eventually diversified into food and beverage conglomerate RJR Nabisco, which produced everything from Oreos to Tang. The food

Do statins really cause those side effects? What the data shows

Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking them stop.

Hospitals stop gender care for minors amid federal pressure

In a concerning trend, at least nine hospitals or health systems across the United States have made the decision to

Raw milk, Super Bowl ads, HHS anti-fraud effort: Morning Rounds

If you're looking to stay informed about the latest developments in health and medicine, look no further than STAT's free

Vertex’s CRISPR sickle cell treatment faces a costly bottleneck

Vertex executives had previously cautioned that the rollout of Casgevy, their groundbreaking curative treatment for sickle cell disease, would be